Heartland CannAssist is proud to announce our newest partntership with Extract Lab. Their Colorado grown full spectrum CBD products lab tested and made with only the highest quality hemp oil. By keeping every step of production in-house, They are able to keep their prices affordable and maintain the quality we and you expect.
Extract Labs is an industry leader in the development of minor cannabinoid products. Their CBG (cannabigerol) products are extracted and processed from American grown hemp in their Boulder, Colorado headquarters. Full spectrum CBG oil features a 1:1 ratio of CBG to CBD. With 500MG of CBG and 500MG of CBD, this C02-extracted hemp oil sourced from Colorado hemp is a one of a kind product. Heartland CannAssist is excited to bring this product to you and it is flying off the shelf! Contact us today to order your bottle.
What is CBG?
By now, most people familiar with cannabis have heard of THC (tetrahydrocannabinol) and CBD (cannabidiol) and their effects, but did you know there are many similar compounds in cannabis? A lesser-known cannabinoid called cannabigerol (CBG), while not present in large quantities in most strains, is nonetheless worth learning about for a number of reasons.
How is CBG (cannabigerol) made?
Because it is present in low levels (usually less than 1%) in most cannabis strains, CBG is considered a minor cannabinoid. Cannabis plants produce cannabigerolic acid (CBGA), the precursor to the three main cannabinoid lines: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromenic acid (CBCA). CBG was first discovered by researchers in the 1960’s. CBG is the precursor from which all other cannabinoids are synthesized, which is why it’s often referred to as the “mother” or “stem cell” of cannabinoids. This unique property imbues CBG with enormous therapeutic promise, making it a subject of great interest for researchers and consumers alike.
The US government is also keen on learning more about CBG. In 2018 The National Center for Complementary and Integrative Health (NCCIH) announced an intent to research minor cannabinoids including CBG that could help manage pain.
While the research conducted on CBG is still in its infancy, what we do know about CBG is very promising.
“We know that CBG shows promise as an antibacterial agent and an anti-inflammatory,” says John Huemoeller, CEO of AXIM Biotechnologies, Inc.
The potential health benefits of CBG are extensive. A non-intoxicating compound, it’s thought to help regulate mood thanks to its ability to boost anandamide, the body’s native “bliss” molecule, as well as act as a GABA reuptake inhibitor. CBG is also a potent neuroprotectant and is currently being evaluated for its ability to combat ailments like Huntington’s Disease. It also is promising and is being researched for cancer fighting properties and is a potent antibacterial that can even treat MRSA.
Despite the medical appeal and consumer demand there’s one big hurdle to face, though: CBG is notoriously expensive to produce, so much so it’s been dubbed the “the Rolls Royce of cannabinoids.” Nobody had been breeding cannabis strains high in CBG until recently.
Potential Benefits of CBG
Animal studies have shown that CBG stimulates receptors involved in pain and heat sensation and can also stimulate a2-adrenergic receptors in the brain and blood vessels, which are involved in blood pressure regulation. Thus, CBG might have a role in blood pressure regulation and pain. CBG may have some anti-inflammatory properties as well.
Of course, all of these effects are also seen with CBD, so it’s unclear whether or not CBG, which again is produced by the plant in much lower quantities, has any differentiating properties.
“In regards to specific diseases, there are two animal studies showing that CBG may be beneficial in inflammatory bowel disease (like ulcerative colitis and Crohn’s disease) and Huntington’s disease (an incurable brain disease). Test tube studies have also shown CBG to have anti-bacterial properties and prevent colon cancer,” he adds.
Clearly, though there is some information that indicates promising benefits of CBG, more research and clinical studies need to occur before drawing any major conclusions.
Current CBG and research on its effects
The research on CBG helps to shed some light into its potential. Below we’ve provided links to some interesting articles:
- In animal experiments involving mice, CBG was studied to explore its potential to treat inflammatory bowel disease.
- A recent 2015 study on CBG claims to help protect neurons in mice with Huntington’s disease, which is characterized by nerve cell degeneration in the brain.
- In a study done on CBG and cancer, CBG was shown to inhibit the growth of colorectal cancer cells in mice, thereby slowing colon cancer growth. According to this study, CBG inhibited tumors and chemically-induced colon carcinogenesis, therefore demonstrating a very exciting possibility for a cure for colorectal cancer.
- European research shows evidence that CBG is an effective antibacterial agent, particularly against methicillin-resistant Staphylococcus aureus (MRSA) microbial strains resistant to several classes of drugs. Since the 1950s, topical formulations of cannabis have been effective in skin infections, but researchers at the time were unaware of the plant’s chemical composition.
- In a very recent 2017 study, researchers showed that a form of CBG purified to remove delta-9 THC was a very effective appetite stimulant in rats. This may lead to a novel non-psychotropic therapeutic option for cachexia, the muscle wasting and severe weight loss seen in late stage cancer and other diseases.
- In a study that looked at the effects of five different cannabinoids on bladder contractions, CBG tested best at inhibiting muscle contractions, so it may be a future tool in preventing bladder dysfunction disorders.
Scientists are excited about these initial CBG results and are promoting future research with CBG alone, or CBG in combination with other cannabinoids and therapies for the treatment of multiple maladies. Because it is non-psychotropic, CBG has a promising wide range of potential applications not only for the problems mentioned above, but also a host of health conditions
Why Does Heartland CannAssist Like Extract Labs
CBD and Cancer Research
Extract Labs, is all about giving back and putting good into the world, which is why they are conducting research through Colorado State University to study the effects of CBD on cancer cells. At the time of this writing, they are the only company currently testing CBD and other cannabinoid’s effects on cancer cells through a renowned school!
Extract Labs is supplying all of the CBD isolate and oils being used for research in this study. As they move forward, CSU will be publishing the results of this research and we will be posting updates here as well. So far, things look very promising and Extract Labs is committed to devoting even more resources to keep this research ongoing.